Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Luciano Baronciani, Ian Peake, Reinhard Schneppenheim, Anne Goodeve, Minoo Ahmadinejad, Zahra Badiee, Mohammad Reza Baghaipour, Olga Benitez, Imre Bodó, Ulrich Budde, Andrea Cairo, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Wolf Hassenpflug, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. LeebeekM. F.L. Fernandez, Pier Mannuccio Mannucci, Renato Marino, Nikolas Nikšić, Florian Oyen, Cristina Santoro, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Eva M.K. Zetterberg, Jeroen Eikenboom, Augusto B. Federici, Flora Peyvandi

Research output: Contribution to journalArticlepeer-review


Type 3 von Willebrand disease (VWD3) is a rare and severe bleeding disorder characterized by often undetectable von Willebrand factor (VWF) plasma levels, a recessive inheritance pattern, and heterogeneous genotype. The objective of this study was to identify the VWF defects in 265 European and Iranian patients with VWD3 enrolled in 3WINTERS-IPS (Type 3 Von Willebrand International Registries Inhibitor Prospective Study). All analyses were performed in centralized laboratories. The VWF genotype was studied in 231 patients with available DNA (121 [115 families] from Europe [EU], and 110 [91 families] from Iran [IR]). Among 206 unrelated patients, 134 were homozygous (EU/IR 5 57/77) and 50 were compound heterozygous (EU/IR 5 43/7) for VWF variants. In 22 patients, no or only one variant was found. A total of 154 different VWF variants (EU/IR 5 101/58 [5 shared]) were identified among the 379 affected alleles (EU/IR 5 210/169), of which 48 (EU/IR 5 18/30) were novel. The variants p.Arg1659*, p.Arg1853*, p.Arg2535*, p.Cys275Ser, and delEx1_Ex5 were found in both European and Iranian VWD3 patients. Sixty variants were identified only in a single allele (EU/IR 5 50/10), whereas 18 were recurrent ($3 patients) within 144 affected alleles. Nine large deletions and one large insertion were found. Although most variants predicted null alleles, 21% of patients carried at least 1 missense variant. VWD3 genotype was more heterogeneous in the European population than in the Iranian population, with nearly twice as many different variants. A higher number of novel variants were found in the Iranian VWD3 patients.

Original languageEnglish
Pages (from-to)2987-3001
Number of pages15
JournalBlood advances
Issue number15
Publication statusPublished - Aug 10 2021

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS'. Together they form a unique fingerprint.

Cite this